Urology · Orlando, FL
NPI
1053676650
Since 2012
Specialty
Urology
Code 208800000X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
2101 Park Center Dr Ste 130
Orlando, FL, 32835
Phone (407) 298-6950
Groups this clinician bills Medicare through
Medicare paid, 2024
$118K
1,737 services
Medicare patients, 2024
411
Average age 74
Drug cost, 2024
$272K
4,059 prescriptions
Company payments, 2025
$232
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jason C Sea was code 99214 (office e&m - established), 436 times for 274 patients. In total Jason C Sea billed 1,737 services in 65 codes, and Medicare paid $118K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-05-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 436 | 274 | $88.82 | $39K |
| 81003 Clinical Chemistry | Office | 176 | 135 | $2.20 | $387 |
| 51798 Ultrasound - Nonspecific | Office | 170 | 145 | $7.37 | $1,254 |
| 99204 Office E&M - New | Office | 105 | 105 | $108.70 | $11K |
| 52000 Cystourethroscopy | Office | 65 | 59 | $166.46 | $11K |
| 99213 Office E&M - Established | Office | 52 | 51 | $63.32 | $3,292 |
| 51797 Other Organ Systems | Office | 32 | 18 | $97.08 | $3,107 |
| 51741 Test - Miscellaneous | Office | 28 | 16 | $3.53 | $98.96 |
| 51784 Neurologic | Office | 27 | 17 | $15.12 | $408 |
| 74420 Standard X-ray | Facility | 19 | 16 | $18.69 | $355 |
| 52310 Calculus Removal - Urinary | Office | 19 | 16 | $233.49 | $4,436 |
| 51728 Other Organ Systems | Office | 18 | 15 | $161.10 | $2,900 |
| 99215 Office E&M - Established | Office | 17 | 15 | $140.37 | $2,386 |
| 76872 Ultrasound - Nonspecific | Facility | 17 | 16 | $23.37 | $397 |
| 52332 Cystourethroscopy | Facility | 16 | 16 | $94.42 | $1,511 |
By year: 2022 $110K for 1,318 services; 2023 $89K for 1,084 services; 2024 $118K for 1,737 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81003 Clinical Chemistry | 176 | 135 | $2.20 | $387 |
Medicare prescription drug claims, 2024
In 2024, the drug Jason C Sea prescribed most often to Medicare patients was Tamsulosin Hcl, with 1,380 prescriptions and refills. In total Jason C Sea wrote 4,059 Medicare prescriptions that cost $272K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tamsulosin Hcl Generic | 1,380 | 4,046 | 550 | $18K |
| Finasteride Generic | 1,209 | 3,564 | 475 | $15K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 281 | 285 | 211 | $519 |
| Oxybutynin Chloride Generic | 179 | 501 | 92 | $6,229 |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 164 | 174 | 106 | $1,935 |
| Alfuzosin Hcl Er Alfuzosin Hcl | 126 | 292 | 37 | $1,945 |
| Myrbetriq Mirabegron | 118 | 215 | 31 | $97K |
| Doxycycline Monohydrate Generic | 70 | 71 | 69 | $3,527 |
| Sildenafil Citrate Generic | 66 | 73 | 21 | $848 |
| Cephalexin Generic | 51 | 54 | 37 | $610 |
| Tolterodine Tartrate Er Tolterodine Tartrate | 48 | 120 | 20 | $4,642 |
| Oxybutynin Chloride Er Oxybutynin Chloride | 40 | 118 | 13 | $1,459 |
| Cefdinir Generic | 36 | 36 | 35 | $1,279 |
| Solifenacin Succinate Generic | 35 | 105 | 18 | $2,441 |
| Dutasteride Generic | 24 | 70 | 12 | $721 |
Brand drugs: - claims; generic drugs: 3,884 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jason C Sea $232 ($232 in general payments such as food, travel and fees) from 4 companies. The largest payer was Becton, Dickinson and Company with $152.
| Company | Payments | Amount |
|---|---|---|
| Becton, Dickinson and Company BDX | 5 | $152 |
| Edap Technomed Inc | 1 | $33.91 |
| Coloplast Corp | 1 | $29.2 |
| Verity Pharmaceuticals Inc. | 1 | $16.92 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.